Boothbay Fund Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$3.99M	–	1910
2021 Q2	$3.99M	Buy	+40,000	New	+$3.99M	0.13%	141